Umberto Capece

430 total citations
19 papers, 244 citations indexed

About

Umberto Capece is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Umberto Capece has authored 19 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Umberto Capece's work include Diabetes Treatment and Management (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Pancreatic function and diabetes (6 papers). Umberto Capece is often cited by papers focused on Diabetes Treatment and Management (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Pancreatic function and diabetes (6 papers). Umberto Capece collaborates with scholars based in Italy, Denmark and Montenegro. Umberto Capece's co-authors include Andrea Giaccari, Francesca Cinti, Teresa Mezza, Gianfranco Di Giuseppe, Alfredo Pontecorvi, Simona Moffa, C. Cefalo, Pietro Manuel Ferraro, Antonio Gasbarrini and Enrico Celestino Nista and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Umberto Capece

19 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Umberto Capece Italy 9 96 89 73 61 55 19 244
Hajnalka Lőrincz Hungary 11 59 0.6× 64 0.7× 74 1.0× 78 1.3× 84 1.5× 53 351
Lamia Amoura France 8 102 1.1× 56 0.6× 56 0.8× 123 2.0× 49 0.9× 16 311
Claudia E. Ramirez United States 10 70 0.7× 93 1.0× 109 1.5× 59 1.0× 49 0.9× 16 372
Masahito Kajiya Japan 11 58 0.6× 100 1.1× 122 1.7× 82 1.3× 71 1.3× 16 354
Keisuke Okawa Japan 12 34 0.4× 72 0.8× 231 3.2× 69 1.1× 43 0.8× 34 384
Eli D. Casalini United States 8 44 0.5× 82 0.9× 55 0.8× 79 1.3× 39 0.7× 11 286
Gianfranco Di Giuseppe Italy 10 89 0.9× 94 1.1× 22 0.3× 93 1.5× 57 1.0× 27 257
Martina Franzese Italy 6 130 1.4× 59 0.7× 48 0.7× 76 1.2× 52 0.9× 6 229
Armando Puocci Italy 6 130 1.4× 59 0.7× 48 0.7× 76 1.2× 52 0.9× 6 229
Kumiko Kaifu Japan 12 194 2.0× 86 1.0× 118 1.6× 88 1.4× 71 1.3× 15 426

Countries citing papers authored by Umberto Capece

Since Specialization
Citations

This map shows the geographic impact of Umberto Capece's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umberto Capece with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umberto Capece more than expected).

Fields of papers citing papers by Umberto Capece

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umberto Capece. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umberto Capece. The network helps show where Umberto Capece may publish in the future.

Co-authorship network of co-authors of Umberto Capece

This figure shows the co-authorship network connecting the top 25 collaborators of Umberto Capece. A scholar is included among the top collaborators of Umberto Capece based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umberto Capece. Umberto Capece is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Cinti, Francesca, A. Guarneri, Luigi Cappannoli, et al.. (2025). Coronary flow reserve increase after 4-year dapagliflozin treatment in patients with type 2 diabetes: the DAPAHEART follow-up study. Cardiovascular Diabetology. 24(1). 351–351. 2 indexed citations
2.
Giuseppe, Gianfranco Di, Pietro Manuel Ferraro, Giuseppe Quero, et al.. (2024). Reduced incretin effect precedes diabetes development following duodenopancreatectomy in individuals without diabetes. Journal of Clinical Investigation. 134(8). 5 indexed citations
3.
Medenica, Sanja, Umberto Capece, Rossella Mazzilli, et al.. (2024). The interlink between thyroid autoimmunity and type 1 diabetes and the impact on male and female fertility. HORMONES. 23(3). 429–437. 1 indexed citations
4.
Giuseppe, Gianfranco Di, Giuseppe Quero, Enrico Celestino Nista, et al.. (2024). Beta-cell function and glucose metabolism in patients with chronic pancreatitis. European Journal of Internal Medicine. 128. 112–118. 2 indexed citations
5.
Capece, Umberto, Teresa Mezza, Alfredo Cesario, et al.. (2024). Real-world evidence evaluation of LDL-C in hospitalized patients: a population-based observational study in the timeframe 2021–2022. Lipids in Health and Disease. 23(1). 224–224. 2 indexed citations
6.
Capece, Umberto, Gianfranco Di Giuseppe, Teresa Mezza, et al.. (2024). SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives. Cardiovascular Diabetology. 23(1). 449–449. 18 indexed citations
7.
Capece, Umberto, A.W. Avolio, Gianfranco Di Giuseppe, et al.. (2024). Erythrocyte Membrane Fluidity and Omega-3 Fatty Acid Intake: Current Outlook and Perspectives for a Novel, Nutritionally Modifiable Cardiovascular Risk Factor. Nutrients. 16(24). 4318–4318. 2 indexed citations
8.
Cinti, Francesca, Lucia Leccisotti, Umberto Capece, et al.. (2024). 140-OR: The Coronary Flow Reserve Increase after Dapagliflozin Treatment in Patients with Type 2 Diabetes Is Maintained after Four Years—A Four-Year DAPAHEART Follow-up Study. Diabetes. 73(Supplement_1). 1 indexed citations
9.
Capece, Umberto, Chiara Pavanello, Francesca Cinti, et al.. (2023). Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide Production. Diabetes Therapy. 15(1). 257–268. 6 indexed citations
10.
Moffa, Simona, Teresa Mezza, Pietro Manuel Ferraro, et al.. (2023). Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study. Frontiers in Endocrinology. 14. 1124116–1124116. 1 indexed citations
11.
Giuseppe, Gianfranco Di, Umberto Capece, C. Cefalo, et al.. (2023). First-phase insulin secretion: can its evaluation direct therapeutic approaches?. Trends in Endocrinology and Metabolism. 34(4). 216–230. 19 indexed citations
12.
Cinti, Francesca, Lucia Leccisotti, Gian Pio Sorice, et al.. (2023). Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes. Cardiovascular Diabetology. 22(1). 349–349. 27 indexed citations
13.
Giuseppe, Gianfranco Di, Simona Moffa, Umberto Capece, et al.. (2023). Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function. Nutrients. 15(19). 4202–4202. 12 indexed citations
14.
Leccisotti, Lucia, Francesca Cinti, Gian Pio Sorice, et al.. (2022). Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report. Cardiovascular Diabetology. 21(1). 173–173. 44 indexed citations
15.
Capece, Umberto, Simona Moffa, Gianfranco Di Giuseppe, et al.. (2022). Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features. Nutrients. 15(1). 18–18. 50 indexed citations
16.
Mezza, Teresa, Pietro Manuel Ferraro, Gianfranco Di Giuseppe, et al.. (2021). Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes. Journal of Clinical Investigation. 131(12). 26 indexed citations
17.
Sorice, Gian Pio, Francesca Cinti, Lucia Leccisotti, et al.. (2021). Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial. Diabetes Therapy. 12(7). 2101–2113. 8 indexed citations
18.
Giuseppe, Gianfranco Di, C. Cefalo, Francesca Cinti, et al.. (2021). Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences. Minerva Endocrinology. 46(3). 272–292. 11 indexed citations
19.
Mezza, Teresa, Simona Moffa, Pietro Manuel Ferraro, et al.. (2019). Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis. The Journal of Clinical Endocrinology & Metabolism. 104(7). 2685–2694. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hajnalka Lőrincz Breakdown of academic impact, for papers by Lamia Amoura Breakdown of academic impact, for papers by Claudia E. Ramirez Breakdown of academic impact, for papers by Masahito Kajiya Breakdown of academic impact, for papers by Keisuke Okawa Breakdown of academic impact, for papers by Eli D. Casalini Breakdown of academic impact, for papers by Gianfranco Di Giuseppe Breakdown of academic impact, for papers by Martina Franzese Breakdown of academic impact, for papers by Armando Puocci Breakdown of academic impact, for papers by Kumiko Kaifu
Rankless by CCL
2026